Abstract: User engagement has recently received significant attention in understanding the decay and expansion of communities in many online social networking platforms. Many user engagement studies ...

Vertex, Inc. shares have plunged over 60% YTD, but valuation is now compelling after a post-earnings dip. Learn more about VERX stock here.

Vertex Pharmaceuticals chief Reshma Kewalramani said AI could reduce the time spent on drug-approval paperwork from months to ...

Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $4.58 per share, up from $4.38 per share in the year-ago period. The consensus estimate for Vertex ...

With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...

Vertex stock dipped Tuesday on a mixed third-quarter report, with the lion's share of its sales beat coming from its older CF ...

We expect Vertex Pharmaceuticals VRTX to surpass expectations when it reports its third-quarter 2025 results on Nov. 3, after ...

While the launches of Journavx and Casgevy have started to build steam, “investors may not be inclined to look past the clear ...

At this time last season, entering the Jets’ seventh game, Will McDonald IV was already in the middle of a breakout year. He had already collected his seventh sack. Gang Green’s edge rusher reality — ...

The Liberal Democratic Party and Japan Innovation Party (JIP) agreed to form a coalition Monday, making it almost certain that LDP President Sanae Takaichi, who had struggled to find a new ally, will ...

'We wanted to do good but I didn't expect to be that good' - Unbeatable Paul Magnier celebrates five bunch sprints out of five at Tour of Guangxi Road Paul Magnier sprints to victory on stage 1 of ...